ICAR-CMFRI commercialized Nutraceuticals for use against arthritis, type-2 diabetes and hypertension to Pioneer Pharmaceuticals Limited-a leading wellness and Pharmaceutical Company based at Kochi
CadalminTM Green Algal extract (CadalminTM GAe), Antidiabetic extract (CadalminTM ADe), and Antihypertensive extract (CadalminTM AHe), three patent-protected nutraceutical products developed by ICAR-Central Marine Fisheries Research Institute, as natural remedies for joint pain/arthritis, type-2 diabetes and hypertensive disorders from seaweeds, were commercialized with Pioneer Pharmaceuticals Limited-a leading wellness and pharmaceutical company based at Kochi. Seaweeds are the natural bounty of the Sea, and are known for their extraordinary medicinal properties.
Dr. A. Gopalakrishnan, Director, ICAR-CMFRI signed an exclusive license agreement with Mrs. Nancy Joby (Managing Partner), along with Mr. Joby George, Joel Joby George, Mathews Simon and B.C Kumar on 9th September for their commercial production and marketing.
Nutraceuticals for use against arthritis, type-2 diabetes and hypertension
Seaweeds are commonly available in the Indian coastal waters, and are gaining immense attention in nutraceutical industries due to their protective function against various chronic diseases
CMFRI adjudged as best research institute under ICAR
CMFRI wins ICAR’s highest award
The Central Marine Fisheries Research Institute (CMFRI) has been adjudged as the best research institute of the Indian Council of Agricultural Research (ICAR). The CMFRI won the Sardar Patel Outstanding ICAR institutions award, the highest award of the ICAR in the category of the large institutions with a cash prize of Rs 10 Lakhs, a Silver Plaque, Certificate and Citation.This is in recognition of CMFRI’s excellent performance in marine fisheries research during the period from 2014 to 2019.
This is the second time CMFRI bagging this prestigious award. Various cutting edge research activities including development of mariculture technologies such as open sea cage fish farming, seaweed farming, integrated multi-trophic aquaculture (IMTA) and breeding and seed production technologies for marine food fish and ornamental fishes which were aimed to enhance the income of fishermen helped CMFRI achieving the highest ranking among more than 110 agricultural and allied research institutes in the country. CMFRI’s efforts on preparing a range of policy guidelines, including the works on minimum legal size (MLS), National Policy on Mariculture and ecosystem-based management towards the sustainable utilization of marine fisheries resources were well appreciated. Its research initiatives in developing nutraceutical products from marine organisms to treat type 2 diabetes, arthritis, obesity, thyroid and hypertension also played a major role in winning the award. In addition, the institute exhibited leadership in winning several externally funded research projects such as National Brood bank for Cobia and Silver pompano and a Centre of Excellence and Innovation funded by the DBT. The institute also obtained many patents during the period.